Literature DB >> 19117132

Clinical significance of anti-HEV IgA in diagnosis of acute genotype 4 hepatitis E virus infection negative for anti-HEV IgM.

Shujun Zhang1, Deying Tian, Zhengang Zhang, Junhui Xiong, Quan Yuan, Shengxiang Ge, Jun Zhang, Ningshao Xia.   

Abstract

Anti-HEV IgM is a diagnostic for recent or ongoing HEV infection. However, some patients with acute hepatitis E (AHE) negative for anti-HEV IgM in acute period were often observed in clinical practice. In this study, we constructed the anti-HEV IgA indirect ELISA assay to evaluate the significance of anti-HEV IgA. The specificity of anti-HEV IgA was 99.6%. Among 245 AHE patients, 84 samples from 84 patients were positive for HEV RNA. The positive rate of anti-HEV IgA, anti-HEV IgM and anti-HEV IgG in 84 samples positive for HEV RNA was 96.3, 97.6, and 88.1%, respectively, and no sample was negative for anti-HEV IgA and anti-HEV IgM simultaneously. Among 245 AHE patients, we found nine samples collected from nine patients in acute period were negative for anti-HEV IgM but positive for anti-HEV IgA and two samples were positive for HEV RNA. Detection of anti-HEV IgA can be a useful supplement for diagnosis of acute HEV infection especially in patients negative for anti-HEV IgM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117132     DOI: 10.1007/s10620-008-0657-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4.

Authors:  Y Wang; H Zhang; Z Li; W Gu; H Lan; W Hao; R Ling; H Li; T J Harrison
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Hepatitis E and long-term antibody status.

Authors:  M S Khuroo; S Kamili; M Y Dar; R Moecklii; S Jameel
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

4.  A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.

Authors:  Shao W Li; Jun Zhang; Yi M Li; Shan H Ou; Guo Y Huang; Zhi Q He; Sheng X Ge; Yang L Xian; Shu Q Pang; Mun H Ng; Ning S Xia
Journal:  Vaccine       Date:  2005-04-22       Impact factor: 3.641

5.  Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3.

Authors:  M Herremans; E Duizer; E Jusic; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

6.  Short-term IgM and IgG antibody responses to hepatitis E virus infection.

Authors:  A Koshy; S Grover; K C Hyams; M A Shabrawy; A Pacsa; B al-Nakib; S A Zaidi; A A al-Anezi; S al-Mufti; J Burans; M Carl; A L Richards
Journal:  Scand J Infect Dis       Date:  1996

7.  Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan.

Authors:  Hitoshi Mizuo; Kazuyuki Suzuki; Yasuhiro Takikawa; Yoshiki Sugai; Hajime Tokita; Yoshihiro Akahane; Keiichi Itoh; Yuhko Gotanda; Masaharu Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

Review 8.  Hepatitis E virus.

Authors:  Suzanne U Emerson; Robert H Purcell
Journal:  Rev Med Virol       Date:  2003 May-Jun       Impact factor: 6.989

9.  Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children.

Authors:  R Goldsmith; P O Yarbough; G R Reyes; K E Fry; K A Gabor; M Kamel; S Zakaria; S Amer; Y Gaffar
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

Review 10.  Genetic variability and evolution of hepatitis E virus.

Authors:  Hiroaki Okamoto
Journal:  Virus Res       Date:  2007-03-23       Impact factor: 3.303

View more
  13 in total

Review 1.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

2.  Performance of Hepatitis E Virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany.

Authors:  Frauke Mara Sommerkorn; Birgit Schauer; Thomas Schreiner; Helmut Fickenscher; Andi Krumbholz
Journal:  Med Microbiol Immunol       Date:  2017-04-10       Impact factor: 3.402

Review 3.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

4.  Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.

Authors:  Andi Krumbholz; Sebastian Joel; Paul Dremsek; Anne Neubert; Reimar Johne; Ralf Dürrwald; Mario Walther; Thomas H Müller; Detlef Kühnel; Jeannette Lange; Peter Wutzler; Andreas Sauerbrei; Rainer G Ulrich; Roland Zell
Journal:  Med Microbiol Immunol       Date:  2014-04-18       Impact factor: 3.402

5.  Clinical characteristics and risk factors of sporadic Hepatitis E in central China.

Authors:  Shujun Zhang; Jingjing Wang; Quan Yuan; Shengxiang Ge; Jun Zhang; Ningshao Xia; Deying Tian
Journal:  Virol J       Date:  2011-04-01       Impact factor: 4.099

6.  Prevalence of hepatitis E virus in slaughter-age pigs in Scotland.

Authors:  C Crossan; S Grierson; J Thomson; A Ward; J Nunez-Garcia; M Banks; L Scobie
Journal:  Epidemiol Infect       Date:  2014-11-20       Impact factor: 4.434

7.  Diagnostic Value of IgA Antibody Measurement in Tick-Borne Spotted Fever (Astrakhan Rickettsial Fever).

Authors:  Nina S Smirnova; Alexey V Kostarnoy; Alexey V Kondratev; Petya G Gancheva; Daniil A Grumov; Alexander L Gintsburg
Journal:  Microbiol Spectr       Date:  2022-04-25

8.  Use of immuno-dominant epitope derived from genotype 4 as a diagnostic reagent for detecting the antibodies against Hepatitis E Virus.

Authors:  Bing-shui Xiu; Xiao-yan Feng; Jing He; Kun Chen; Jing Liu; Zhen-hua Dai; Xi-qin Yang; Guo-hua Wang; You-chun Wang; He-qiu Zhang; Xiao-guo Song; Cui-xia Zhu
Journal:  Virol J       Date:  2013-04-25       Impact factor: 4.099

Review 9.  Transmission, diagnosis, and management of hepatitis E: an update.

Authors:  Santiago Mirazo; Natalia Ramos; Victoria Mainardi; Solange Gerona; Juan Arbiza
Journal:  Hepat Med       Date:  2014-06-03

10.  Hepatitis E virus prevalence among blood donors in Dali, China.

Authors:  Ping Fu; Baochai Lin; Bingting Wu; Ling Ke; Tianfu Yang; Yue'e Du; Lishan Cheng; Zhou Li; Tiancheng Li; Yu Liu
Journal:  Virol J       Date:  2021-07-07       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.